Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Multiple Myeloma × Sensitivity and Specificity × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Leukemia, Prolymphocytic, B-Cell 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Myeloid, Acute 2 Study of Risk Factors for IPMNs Degeneration at the Nancy CHRU 1 Stomach Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Myeloid 1 Leukemia, Large Granular Lymphocytic 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Dexamethasone 54 Cyclophosphamide 35 Bortezomib 29 Melphalan 22 Lenalidomide 18 pomalidomide 14 Thalidomide 14 fludarabine 10 daratumumab 9 carfilzomib 7 Filgrastim 7 Doxorubicin 6 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Bendamustine Hydrochloride 5 ixazomib 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Mycophenolic Acid 4 Clarithromycin 4 Calcium Dobesilate 4 selinexor 3 sargramostim 3 liposomal doxorubicin 3 isatuximab 3 Radiotherapy 3 Neoadjuvant Therapy 3 Methylprednisolone 3 Interferon-alpha 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01886976 2016-01-28

CART-138

Chinese PLA General Hospital

Phase 1/2 Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡